Viral medicines include gene therapies, vaccines and oncolytic viruses. We understand the barriers holding drug developers and manufacturers back from achieving the potential of your products and services. Our proprietary and pioneering Viral Sensitizers (VSE™) unlock the potential to increase yield and effectiveness at better margins.

From viral medicines manufacturing to anti-cancer therapy, Virica addresses unmet needs in production and development to positively change human health. Our VSEs improve and optimize your processes to deliver high-yield products at a lower unit cost.

We offer you insightful and educational resources to enhance your scientific knowledge of viral medicine development and production.

We pioneered a new product category of Viral Sensitizers that removes the barriers to achieve scalability and effectiveness in the production of viral medicines. Customized VSE formulations optimize research processes and enhance production. VSEs help bring your treatments to patients on an accelerated timeline.

Check in often to read about our career opportunities.